FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

150851000036107: calcium pantothenate 20 mg + colecalciferol 400 international units + copper + d-alpha-tocopheryl acid succinate 150 international units + magnesium (as oxide heavy) 150 mg + nicotinamide 20 mg + rutoside 250 mg + tanacetum parthenium 150 mg + thiamine hydrochloride 20 mg tablet, 30 tablets (medicinal product pack)

  • Australian concept\Australian product\medicinal product pack\rutoside 250 mg + magnesium (as oxide heavy) 150 mg + feverfew 150 mg + copper + calcium pantothenate 20 mg + nicotinamide 20 mg + thiamine hydrochloride 20 mg + d-alpha-tocopheryl acid succinate 124 mg (150 units) + colecalciferol 10 microgram (400 units) tablet, 30

Status: current, Defined. Date: 30-Nov 2013. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2573611000168117 rutin 250 mg + magnesium (as oxide heavy) 150 mg + feverfew 150 mg + copper + calcium pantothenate 20 mg + nicotinamide 20 mg + thiamine hydrochloride 20 mg + d-alpha-tocopheryl acid succinate 124 mg (150 units) + cholecalciferol 10 microgram (400 units) tablet, 30 en Synonym Active Case sensitive Australian Medicines Terminology module
729901000036118 rutoside 250 mg + magnesium (as oxide heavy) 150 mg + feverfew 150 mg + copper + calcium pantothenate 20 mg + nicotinamide 20 mg + thiamine hydrochloride 20 mg + d-alpha-tocopheryl acid succinate 124 mg (150 units) + colecalciferol 10 microgram (400 units) tablet, 30 en Synonym Active Case sensitive Australian Medicines Terminology module
729911000036116 calcium pantothenate 20 mg + colecalciferol 400 international units + copper + d-alpha-tocopheryl acid succinate 150 international units + magnesium (as oxide heavy) 150 mg + nicotinamide 20 mg + rutoside 250 mg + tanacetum parthenium 150 mg + thiamine hydrochloride 20 mg tablet, 30 tablets (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
rutoside 250 mg + magnesium (as oxide heavy) 150 mg + feverfew 150 mg + copper + calcium pantothenate 20 mg + nicotinamide 20 mg + thiamine hydrochloride 20 mg + d-alpha-tocopheryl acid succinate 124 mg (150 units) + colecalciferol 10 microgram (400 units) tablet, 30 Is a medicinal product pack true Inferred relationship Some
rutoside 250 mg + magnesium (as oxide heavy) 150 mg + feverfew 150 mg + copper + calcium pantothenate 20 mg + nicotinamide 20 mg + thiamine hydrochloride 20 mg + d-alpha-tocopheryl acid succinate 124 mg (150 units) + colecalciferol 10 microgram (400 units) tablet, 30 has MPUU rutoside 250 mg + magnesium (as oxide heavy) 150 mg + feverfew 150 mg + copper + calcium pantothenate 20 mg + nicotinamide 20 mg + thiamine hydrochloride 20 mg + d-alpha-tocopheryl acid succinate 124 mg (150 units) + colecalciferol 10 microgram (400 units) tablet true Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Crampeze Night Cramps Forte tablet, 30 Is a True rutoside 250 mg + magnesium (as oxide heavy) 150 mg + feverfew 150 mg + copper + calcium pantothenate 20 mg + nicotinamide 20 mg + thiamine hydrochloride 20 mg + d-alpha-tocopheryl acid succinate 124 mg (150 units) + colecalciferol 10 microgram (400 units) tablet, 30 Inferred relationship Some

Reference Sets

List of Excluded Medicinal Items reference set

Medicinal product pack reference set

Back to Start